We are live on
!
Find out more
CAC
Core Alternative Capital Portfolio holdings
AUM
$339M
1-Year Est. Return
18.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.38%
1 Year Est. Return
+18.22%
3 Year Est. Return
+57.45%
5 Year Est. Return
+82.24%
10 Year Est. Return
–
AUM
$558M
AUM Growth
-$25.3M
(-4.3%)
Cap. Flow
-$61.3M
Cap. Flow
% of AUM
-10.98%
Top 10 Holdings %
Top 10 Hldgs %
30.28%
Holding
381
New
17
Increased
25
Reduced
294
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$447K |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$403K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$288K |
| 4 |
Medtronic
MDT
|
+$286K |
| 5 |
TE Connectivity
TEL
|
+$281K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.75M |
| 2 |
Microsoft
MSFT
|
+$3M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.91M |
| 4 |
Merck
MRK
|
+$2.52M |
| 5 |
Broadridge
BR
|
+$2.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.14% |
| 2 | Financials | 15.17% |
| 3 | Healthcare | 13.18% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Carrier Global
CARR
$57.2B
| $43.1K | 0.01% |
741
-234
| -24% | -$13.1K |
|
152
Regeneron Pharmaceuticals
REGN
$68.8B
| $41.4K | 0.01% |
43
-12
| -22% | -$11.4K |
|
153
WEX
WEX
$6.11B
| $40.6K | 0.01% |
171
| – | – |
|
154
Synopsys
SNPS
$71.5B
| $40.6K | 0.01% |
71
-41
| -37% | -$22.6K |
|
155
Capital One
COF
$124B
| $39K | 0.01% |
262
-165
| -39% | -$22.3K |
|
156
Qualcomm
QCOM
$176B
| $38.9K | 0.01% |
230
-164
| -42% | -$25.3K |
|
157
Phillips 66
PSX
$82.9B
| $38.5K | 0.01% |
236
-882
| -79% | -$127K |
|
158
Bristol-Myers Squibb
BMY
$127B
| $38K | 0.01% |
700
-992
| -59% | -$50.5K |
|
159
EOG Resources
EOG
$78B
| $36.3K | 0.01% |
284
-43
| -13% | -$5.02K |
|
160
Emcor
EME
$33.1B
| $34.7K | 0.01% |
99
| – | – |
|
161
TransDigm Group
TDG
$69.2B
| $34.5K | 0.01% |
28
-47
| -63% | -$52.9K |
|
162
Ross Stores
ROST
$76.6B
| $33K | 0.01% |
225
-103
| -31% | -$14.8K |
|
|
DASTY
163
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
| $33K | 0.01% |
+745
| New | +$33K |
|
164
Equinix
EQIX
$107B
| $32.2K | 0.01% |
39
-69
| -64% | -$58K |
|
165
Zoetis
ZTS
$31.6B
| $31K | 0.01% |
183
-55
| -23% | -$10.3K |
|
166
ServiceNow
NOW
$102B
| $29.7K | 0.01% |
195
-225
| -54% | -$34.1K |
|
167
PNC Financial Services
PNC
$100B
| $29.6K | 0.01% |
183
-118
| -39% | -$17.8K |
|
168
AvalonBay Communities
AVB
$27.1B
| $29.5K | 0.01% |
159
-44
| -22% | -$7.91K |
|
169
T-Mobile US
TMUS
$193B
| $28.9K | 0.01% |
177
-106
| -37% | -$17.3K |
|
170
HCA Healthcare
HCA
$84.8B
| $28K | 0.01% |
84
-37
| -31% | -$11.3K |
|
171
Republic Services
RSG
$66.7B
| $27.6K | ﹤0.01% |
144
+3
| +2% | +$532 |
|
172
Amphenol
APH
$188B
| $26.6K | ﹤0.01% |
462
-280
| -38% | -$14.7K |
|
173
McKesson
MCK
$98.5B
| $26.3K | ﹤0.01% |
49
-38
| -44% | -$19.3K |
|
174
O'Reilly Automotive
ORLY
$72.4B
| $26K | ﹤0.01% |
345
+30
| +10% | +$2.1K |
|
175
Boston Scientific
BSX
$65.8B
| $25.3K | ﹤0.01% |
370
-611
| -62% | -$39.3K |
|
Similar funds
PB
CWM
BAM
WCM
VCM
BCM
SCM
JCIA
Core Alternative Capital's Q1 2024 Portfolio in Review
As of Q1 2024, Core Alternative Capital held 381 positions worth $558M, down 4.3% from $583M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Core Alternative Capital withdrew a net $61.3M in Q1 2024, closing 27 positions and reducing 294 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $543K position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Core Alternative Capital opened a new position in iShares Core S&P 500 ETF worth $470K.
- Core Alternative Capital's largest Q1 2024 buy was iShares Core S&P 500 ETF: 894 shares worth $470K.
- Core Alternative Capital added most to Alphabet (Google) Class C in Q1 2024, an estimated $403K increase.
- Core Alternative Capital's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $4.75M.
- Core Alternative Capital fully exited Berkshire Hathaway Class A in Q1 2024, selling an estimated $543K.
- Core Alternative Capital's ten largest holdings make up 30% of its $558M portfolio in Q1 2024.
- Core Alternative Capital opened 17 new positions and closed 27 in Q1 2024.
- Core Alternative Capital's portfolio value fell 4.3% quarter-over-quarter to $558M.
Based on Core Alternative Capital's 13F filing for Q1 2024, filed 15 May 2024.